Prognostic indicators of cardiovascular risk in renal disease

Frontiers in Physiology

Volumn 2 JAN, Issue , 2012, Pages

  Hildreth, Cara M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Baroreceptor reflex sensitivity; End stage renal disease; Heart rate variability

Indexed keywords

EID: 84866300387     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00121     Document Type: Article

References (67)

1. Agarwal, A., Anand, I. S., Sakhuja, V., and Chugh, K. S. (1991). Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int. 40, 489-495.
2. Bavanandan, S., Ajayi, S., Fentum, B., Paul, S. K., Carr, S. J., and Robinson, T. G. (2005). Cardiac barorecep-tor sensitivity: a prognostic marker in predialysis chronic kidney disease patients[quest]. Kidney Int. 67, 1019-1027.
3. Brotman, D. J., Bash,L. D., Qayyum, R., Crews, D., Whitsel, E. A., Astor, B. C., and Coresh, J. (2010). Heart rate variability predicts ESRD and CKD-related hospitalization. J. Am. Soc. Nephrol. 21, 1560-1570.
4. Burger, A. J., D'elia, J. A., Wein-rauch, L. A., Lerman, I., and Gaur, A. (2002). Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy. Int. J. Cardiol. 86, 281-287.
5. Celik,A., Melek, M.,Yuksel, S., Onrat, E., and Avsar, A. (2011). Cardiac auto-nomic dysfunction in hemodialysis patients: the value of heart rate turbulence. Hemodial. Int. 15, 193-199.
6. Chan, C. T., Hanly, P., Gabor, J., Pic-ton, P., Pierratos, A., and Floras, J. S. (2004). Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypox-emia during sleep. Kidney Int. 65, 661-665.
7. Chan, C. T., Harvey, P. J., Picton, P., Pier-ratos, A., Miller, J. A., and Floras, J. S. (2003). Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 42, 925-931.
8. Chan, C. T., Jain,V., Picton, P., Pierratos, A., and Floras, J. S. (2005). Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int. 68, 338-344.
9. Chan, C. T., Shen, X. S., Picton, P., and Floras, J. (2008). Nocturnal home hemodialysis improves baroreflex effectiveness index of end-stage renal disease patients. J. Hypertens. 26, 1795-1800.
10. Chandra, P., Sands, R. L., Gillespie, B. W., Levin, N. W., Kotanko, P., Kiser, M., Finkelstein, F., Hinderliter, A., Pop-Busui, R., Rajagopalan, S., and Saran, R. (2011). Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfr340
11. Chesterton, L. J., Selby, N. M., Burton, J. O., Fialova, J., Chan, C., and Mcintyre, C. W. (2010). Categorization of the hemodynamic response to hemodialysis: the importance of baroreflex sensitivity. Hemodial. Int. 14, 18-28.
12. Chesterton, L. J., Sigrist, M. K., Bennett, T., Taal, M. W., and Mcintyre, C. W. (2005). Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol. Dial. Transplant. 20, 1140-1147.
13. Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., and Victor, R. G. (1992). Sympathetic overactivity in patients with chronic renal failure. N. Eng. J. Med. 327, 1912-1918.
14. Di Rienzo, M., Parati, G., Castiglioni, P., Tordi, R., Mancia, G., and Pedotti, A. (2001). Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R744-R751.
15. Efrati, S., Zaidenstein, R., Dishy, V., Beberashvili, I., Sharist, M., Aver-bukh, Z., Golik, A., and Weissgarten, J. (2002). ACE inhibitors and survival of hemodialysis patients. Am. J. Kidney Dis. 40, 1023-1029.
16. Fang, W., Oreopoulos, D. G., and Bargman, J. M. (2008). Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis. Nephrol. Dial. Transplant. 23, 3704-3710.
17. Fukuta, H., Hayano, J., Ishihara, S., Sakata, S., Mukai, S., Ohte, N., Ojika, K., Yagi, K., Matsumoto, H., Sohmiya, S., and Kimura, G. (2003a). Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol. Dial. Transplant. 18, 318-325.
18. Fukuta, H., Hayano, J., Ishihara, S., Sakata, S., Ohte, N., Takahashi, H., Yokoya, M., Toriyama, T., Kawa-hara, H., Yajima, K., Kobayashi, K., and Kimura, G. (2003b). Prognostic value of nonlinear heart rate dynamics in hemodialysis patients with coronary artery disease. Kidney Int. 64, 641-648.
19. Furuland, H.,Linde, T., Englund,A., and Wikstrom,B. (2008). Heart rate variability is decreased in chronic kidney disease but may improve with hemoglobin normalization. J. Nephrol. 21, 45-52.
20. Gao, S. A., Johansson, M., Hammaren, A., Nordberg, M., and Friberg, P. (2005). Reproducibility of methods for assessing baroreflex sensitivity and temporal QT variability in end-stage renal disease and healthy subjects. Clin. Auton. Res. 15, 21-28.
21. Gerhardt, U., Riedasch, M., Steinmetz, M., and Hohage, H. (1999). Kidney transplantation improves barore-ceptor sensitivity. Int. J. Cardiol. 70, 233-239.
22. Giordano, M., Manzella, D., Paolisso, G., Caliendo, A., Varricchio, M., and Giordano, C. (2001). Differences in heart rate variability parameters during the post-dialytic period in type II diabetic and non-diabetic ESRD patients. Nephrol. Dial. Transplant. 16, 566-573.
23. Grassi, G., Quarti-Trevano, F., Seravalle, G., Arenare, F., Volpe, M., Furiani, S., Dell'oro, R., and Mancia, G. (2011). Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57, 846-851.
24. Grassi, G.,Seravalle, G.,Arenare, F., Buc-cianti, G., Furiani, S.,Ilardo,V., Bolla, G., and Mancia, G. (2009). Behaviour of regional adrenergic outflow in mild-to-moderate renal failure. J. Hypertens. 27, 562-566.
25. Guzik, P., Piskorski, J., Krauze, T., Schneider, R., Wesseling, K. H., Wykretowicz, A., and Wysocki, H. (2007). Correlations between the Poincare plot and conventional heart rate variability parameters assessed during paced breathing. J. Physiol. Sci. 57, 63-71.
26. Hathaway, D. K., Cashion, A. K., Mil-stead, E. J., Winsett, R. P., Cowan, P. A., Wicks, M. N., and Gaber, A. O. (1998). Autonomic dysregulation in patients awaiting kidney transplantation. Am. J. Kidney Dis. 32, 221-229.
27. Hausberg, M., Kosch, M., Harmelink, P., Barenbrock, M., Hohage, H., Kisters, K., Dietl, K. H., and Rahn, K. H. (2002). Sympathetic nerve activity in end-stage renal disease. Circulation 106, 1974-1979.
28. Hayano, J., Takahashi, H., Toriyama, T., Mukai, S., Okada, A., Sakata, S., Yamada, A., Ohte, N., and Kawahara, H. (1999). Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol. Dial. Transplant. 14, 1480-1488.
29. Heber, M. E., Lahiri, A., Thompson, D., and Raftery, E. B. (1989). Barore-ceptor, not left ventricular, dysfunction is the cause of hemodialy-sis hypotension. Clin. Nephrol. 32, 79-86.
30. Herzog, C. A. (2003). Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int. 63, S197-S200.
31. Johansson, M., Gao, S. A., Friberg, P., Annerstedt, M., Bergstrom, G., Carl-strom, J., Ivarsson, T., Jensen, G., Ljungman, S., Mathillas, O., Nielsen, F.-D., and Strombom, U. (2005). Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure[ast]. Am. J. Hypertens. 18, 995-1000.
32. Johansson, M., Gao, S. A., Friberg, P., Annerstedt, M., Carlstrom, J., Ivars-son, T., Jensen, G., Ljungman, S., Mathillas, O., Nielsen, F. D., and Strombom, U. (2007). Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J. Hypertens. 25, 163-168.
33. Karnik, J. A., Young, B. S., Lew, N. L., Herget, M., Dubinsky, C., Lazarus, J. M., and Chertow, G. M. (2001). Cardiac arrest and sudden death in dialysis units. Kidney Int. 60, 350-357.
34. Kataoka, M., Ito, C., Sasaki, H., Yamane, K., and Kohno, N. (2004). Low heart rate variability is a risk factor for sudden cardiac death in type 2 diabetes. Diabetes Res. Clin. Pract. 64, 51-58.
35. Klein, I. H., Ligtenberg, G., Neumann, J., Oey, P. L., Koomans, H. A., and Blankestijn, P. J. (2003). Sympathetic nerve activity is inappropriately increased in chronic renal disease. J. Am. Soc. Nephrol. 14, 3239-3244.
36. Kurata, C., Uehara, A., and Ishikawa, A. (2004). Improvement of cardiac sympathetic innervation by renal transplantation. J. Nucl. Med. 45, 1114-1120.
37. La Rovere, M. T., Bigger, J. T. Jr., Marcus, F. I., Mortara, A., and Schwartz, P. J. (1998). Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocar-dial infarction. ATRAMI (Auto-nomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351, 478-484.
38. La Rovere, M. T., Pinna, G. D., Hohn-loser, S. H., Marcus, F. I., Mor-tara, A., Nohara, R., Bigger, J. T. Jr., Camm, A. J., and Schwartz, P. J. (2001). Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 103, 2072-2077.
39. La Rovere, M. T., Pinna, G. D., Maestri, R., Mortara, A., Capomolla, S., Febo, O., Ferrari, R., Franchini, M., Gnemmi, M., Opasich, C., Riccardi, P. G., Traversi, E., and Cobelli, F. (2003). Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107, 565-570.
40. Lacy, P., Carr, S. J., O'brien, D., Fen-tum, B., Williams, B., Paul, S. K., and Robinson, T. G. (2006). Reduced glomerular filtration rate in pre-dialysis non-diabetic chronic kidney disease patients is associated with impaired baroreceptor sensitivity and reduced vascular compliance. Clin. Sci. 110, 101-108.
41. Lazarus, J. M.,Hampers, C. L.,Lowrie, E. G., and Merrill, J. P. (1973). Barore-ceptor activity in normotensive and hypertensive uremic patients. Circulation 47, 1015-1021.
42. Molgaard, H., Sorensen, K. E., and Bjer-regaard, P. (1991). Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin. Auton. Res. 1, 233-237.
43. Mortara, A., and Tavazzi, L. (1996). Prognostic implications of auto-nomic nervous system analysis in chronic heart failure: role of heart rate variability and baroreflex sensitivity. Arch. Gerontol. Geriatr. 23, 265-275.
44. Mylonopoulou, M., Tentolouris, N., Antonopoulos, S., Mikros, S., Kat-saros, K., Melidonis, A., Sevastos, N., and Katsilambros, N. (2010). Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy. Nephrol. Dial. Transplant. 25, 3749-3754.
45. Parfrey, P. S., and Foley, R. N. (1999). The clinical epidemiology of cardiac disease in chronic renal failure. J. Am. Soc. Nephrol. 10, 1606-1615.
46. Parisotto, V., Lima, E. M., Silva, J. M., De Sousa, M. R., and Ribeiro, A. L. (2008). Cardiac sympathetic dysau-tonomia in children with chronic kidney disease. J. Nucl. Cardiol. 15, 246-254.
47. Park, J., Campese, V. M., Nobakht, N., and Middlekauff, H. R. (2008). Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. J. Appl. Physiol. 105, 1873-1876.
48. Pickering, T. G., Gribbin, B., and Oliver, D. O. (1972). Baroreflex sensitivityin patients on long-term haemodial-ysis. Clin. Sci. 43, 645-657.
49. Pun, P. H., Smarz, T. R., Honeycutt, E F., Shaw, L. K., Al-Khatib, S. M., and Middleton, J. P. (2009). Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int. 76, 652-658.
50. Roumelioti, M. E., Ranpuria, R., Hall, M., Hotchkiss, J. R., Chan, C. T., Unruh, M. L., and Argyropou-los, C. (2010). Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol. Dial. Transplant. 25, 3733-3741.
51. Rubinger, D., Backenroth, R., and Sapoznikov, D. (2009). Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation. Nephrol. Dial. Transplant. 24, 1305-1313.
52. Sahin, M., Kayatas, M., Urun, Y., Sen-naroglu, E., and Akdur, S. (2006). Performing only one cardiovascular reflex test has a high positive predictive value for diagnosing autonomic europathy in patients with chronic renal failure on hemodialysis. Ren. Fail. 28, 383-387.
53. Schwartz, P. J., La Rovere, M. T., and Vanoli, E. (1992). Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 85, I77-I91.
54. Schwartz, P. J., and Stone, H. L. (1980). Left stellectomy in the prevention of ventricular fibrillation causedby acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation 62, 1256-1265.
55. Schwartz, P. J., Vanoli, E., Stramba-Badiale, M., De Ferrari, G. M., Bill-man, G. E., and Foreman, R. D. (1988). Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78, 969-979.
56. Shamseddin, M. K., and Parfrey, P. S. (2011). Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat. Rev. Nephrol. 7, 145-154.
57. Stauss, H. M. (2003). Heart rate variability. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R927-R931.
58. Steinberg, A. A., Mars, R. L., Goldman, D. S., and Percy, R. F. (1998). Effect of end-stage renal disease on decreased heart rate variability. Am. J. Cardiol. 82, 1156-1158, A1110.
59. Studinger, P., Lenard, Z., Mersich, B., Reusz, G. S., and Kollai, M. (2006). Determinants of baroreflex function in juvenile end-stage renal disease. Kidney Int. 69, 2236-2242.
60. Task Force of the ESC and NASPE. (1996). Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93, 1043-1065.
61. Tong, Y. Q., and Hou, H. M. (2007). Alteration of heart rate variability parameters in nondia-betic hemodialysis patients. Am. J. Nephrol. 27, 63-69.
62. U.S. Renal Data System. (2011). USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
63. Yamanaka, N., Aoyama, T., Ikeda, N., Higashihara, M., and Kamata, K. (2005). Characteristics of heart rate variability entropy and blood pressure during hemodialysis in patients with end-stage renal disease. Hemodial. Int. 9, 303-308.
64. Yang, Y. W., Wu, C. H., Tsai, M. K., Kuo, T. B., Yang, C. C., and Lee, P. H. (2010). Heart rate variability during hemodialysis and following renal transplantation.Transplant. Proc. 42, 1637-1640.
65. Yildiz, A., Sever, M. S., Demirel, S., Akkaya, V., Turk, S., Turkmen, A., Ecder, T., and Ark, E. (1998). Improvement of uremic autonomic dysfunction after renal transplantation: a heart rate variability study. Nephron 80, 57-60.
66. Zaza, A., and Lombardi, F. (2001). Auto-nomic indexes based on the analysis of heart rate variability: a view from the sinus node. Cardiovasc. Res. 50, 434-442.
67. Zoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., Cataliotti, A., Stancanelli, B., and Malatino, L. S. (2002). Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105, 1354-1359.